Evidence map›Paper›PMID 36292192›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Combination of Optical Biopsy with Patient Data for Improvement of Skin Tumor Identification.

Yulia Khristoforova, Ivan Bratchenko, Lyudmila Bratchenko, Alexander Moryatov, Sergey Kozlov, Oleg Kaganov, Valery Zakharov

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Lesion Detection and Analysis Using Optical Imaging.Diagnostics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yulia KhristoforovaLaser and Biotechnical Systems Department, Samara National Research University, 34 Moskovskoe Shosse, 443086 Samara, Russia.ORCID 0000-0001-8851-4732
Ivan BratchenkoLaser and Biotechnical Systems Department, Samara National Research University, 34 Moskovskoe Shosse, 443086 Samara, Russia.ORCID 0000-0003-3629-7064
Lyudmila BratchenkoLaser and Biotechnical Systems Department, Samara National Research University, 34 Moskovskoe Shosse, 443086 Samara, Russia.
Alexander MoryatovDepartment of Oncology, Samara State Medical University, 89 Chapaevskaya Str., 443099 Samara, Russia.
Sergey KozlovDepartment of Oncology, Samara State Medical University, 89 Chapaevskaya Str., 443099 Samara, Russia.
Oleg KaganovDepartment of Oncology, Samara State Medical University, 89 Chapaevskaya Str., 443099 Samara, Russia.
Valery ZakharovLaser and Biotechnical Systems Department, Samara National Research University, 34 Moskovskoe Shosse, 443086 Samara, Russia.
Samara National Research University · RUSamara State Medical University · RU

Funding

Russian Science Foundation 21-75-10097
6 · The paper itself

Abstract

In this study, patient data were combined with Raman and autofluorescence spectral parameters for more accurate identification of skin tumors. The spectral and patient data of skin tumors were classified by projection on latent structures and discriminant analysis. The importance of patient risk factors was determined using statistical improvement of ROC AUCs when spectral parameters were combined with risk factors. Gender, age and tumor localization were found significant for classification of malignant versus benign neoplasms, resulting in improvement of ROC AUCs from 0.610 to 0.818 (p < 0.05). To distinguish melanoma versus pigmented skin tumors, the same factors significantly improved ROC AUCs from 0.709 to 0.810 (p < 0.05) when analyzed together according to the spectral data, but insignificantly (p > 0.05) when analyzed individually. For classification of melanoma versus seborrheic keratosis, no statistical improvement of ROC AUC was observed when the patient data were added to the spectral data. In all three classification models, additional risk factors such as occupational hazards, family history, sun exposure, size, and personal history did not statistically improve the ROC AUCs. In summary, combined analysis of spectral and patient data can be significant for certain diagnostic tasks: patient data demonstrated the distribution of skin tumor incidence in different demographic groups, whereas tumors within each group were distinguished using the spectral differences.

Indexed as

cancer risk factorsPLS analysisRaman spectroscopyskin cancerstatistical significance

Identifiers

PMID36292192
PMCPMC9600416
OpenAlexW4306377203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.